Stay updated on Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe webpage has been updated to include new information about a study on Metastatic Colorectal Cancer, including the addition of collaborators and a revision number, while significant details about the study's design, criteria, and treatment regimen have been removed.SummaryDifference42%
- Check15 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check23 days agoNo Change Detected
- Check59 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check73 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check80 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial page.